Low-dose 4-factor PCC for urgent warfarin reversal

被引：0
|
作者：
Zemrak, W. [1 ]
Smith, K. [1 ]
Rolfe, S. [1 ]
Hayes, T. [2 ]
Trowbridge, R. [3 ]
Seder, D. [4 ]
机构：
[1] Maine Med Ctr, Pharm Serv, Portland, ME USA
[2] Maine Med Ctr, Pathol, Portland, ME USA
[3] Maine Med Ctr, Hosp Med, Portland, ME USA
[4] Maine Med Ctr, Crit Care Serv, Portland, ME USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO367-WED
引用
收藏
页码：885 / 885
页数：1
相关论文
共 50 条
  • [41] Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
    Chapman, Scott A.
    Irwin, Eric D.
    Abou-Karam, Nada M.
    Rupnow, Nichole M.
    Hutson, Katherine E.
    Vespa, Jeffrey
    Roach, Robert M.
    WORLD JOURNAL OF EMERGENCY SURGERY, 2014, 9
  • [42] Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure
    Stevenson, Byron
    Roberts, A. Joshua
    Dager, William E.
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 5 - 12
  • [43] Ameta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage
    Coleman, C.
    Karadenes, A.
    Cassano, C.
    Baker, W. L.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [44] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [45] PROSPECTIVE EVALUATION OF A FIXED-DOSE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE PROTOCOL FOR URGENT VITAMIN K ANTAGONIST REVERSAL
    Bitonti, Michael T.
    Rumbarger, Rachel L.
    Absher, Randall K.
    Curran, Lisa M.
    JOURNAL OF EMERGENCY MEDICINE, 2020, 58 (02): : 324 - 329
  • [46] Low-dose oral vitamin K for the reversal of warfarin associated coagulopathy
    Crowther, MA
    Hirsh, J
    Donovan, D
    Harrison, L
    McGinnis, J
    Ginsberg, JS
    BLOOD, 1996, 88 (10) : 699 - 699
  • [47] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [48] Low-Dose 3-Factor Prothrombin Complex Concentrate for Warfarin Reversal Prior to Heart Transplant
    Kantorovich, Alexander
    Fink, Jodie M.
    Militello, Michael A.
    Wanek, Matthew R.
    Smedira, Nicholas G.
    Soltesz, Edward G.
    Moazami, Nader
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (08) : 876 - 882
  • [49] Number needed to treat with 4-factor prothrombin complex concentrate for urgent warfarin reversal (Retraction of vol 91, pg E427, 2016)
    Chua, Andrew
    Patel, Vishal
    Perrin, Allison
    Stern, Lee
    Ehreth, Jenifer
    Omert, Laurel
    Hood, Christopher
    Farley, Julie
    McGlynn, Michael
    Huang, Liping
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : E60 - E60
  • [50] Comparison of 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin in emergency situations.
    Zane, Laura
    Reichert, Marc
    PHARMACOTHERAPY, 2015, 35 (05): : E68 - E69
12345